Global Allergy Immunotherapy Market 2017-2021 Featuring ALK-Abello, Allergy Therapeutics, Merck Group and Stallergenes – Research and Markets

DUBLIN–(BUSINESS WIRE)–The “Global
Allergy Immunotherapy Market (2017-2021 Edition)”
report has
been added to Research and Markets’ offering.

Global Allergy Immunotherapy Market (2017-2021 Edition),
provides an in-depth analysis of the global allergy immunotherapy market
by value, by methods of administration, by region, etc.

The report provides a regional analysis of the allergy immunotherapy
market, including the following regions: the US, Europe and Rest of the
World.

Growth of the overall global allergy immunotherapy market has also been
forecasted for the period 2017-2021, taking into consideration the
previous growth patterns, the growth drivers and the current and future
trends.

The key players of the allergy immunotherapy market ALK-Abello, Allergy
Therapeutics, Merck Group and Stallergenes, who are also profiled with
their financial information and respective business strategies.

The global allergy immunotherapy market has increased at a significant
CAGR during the years 2012-2016 and projections are made that the market
would rise in the next four years i.e. 2017-2021 tremendously. The
allergy immunotherapy market is expected to increase due to growth in
healthcare expenditure, rising incidence of chronic diseases and
increasing global pollution, etc. Yet the market faces some challenges
such as, lack of treatment awareness, lack of investor confidence,
anaphylaxia, huge treatment costs, etc.

Key Topics Covered:

1. Executive Summary

2. Introduction

3. Global Market Analysis

4. Regional Market Analysis

5. Competitive Landscape

6. Company Profiles

  • ALK-Abello
  • Allergy Therapeutics
  • Merck Group
  • Stallergenes

For more information about this report visit https://www.researchandmarkets.com/research/s22bxc/global_allergy

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Immune
Disorders Drugs
, Allergy
Drugs